Skip to content

Latest

Former Lilly CFO to head CVS Caremark

Former Lilly CFO to head CVS Caremark

CVS Health has named former Eli Lilly and Co. chief financial officer Derica Rice as president of its CVS Caremark pharmacy benefit management unit. Plans call for Rice to take the helm at CVS Caremark on March 30, CVS said late Tuesday.

Dr. Reddy’s releases store-brand version of Xyzal Allergy 24HR

Dr. Reddy’s releases store-brand version of Xyzal Allergy 24HR

Dr. Reddy’s Laboratories has launched levocetirizine dihydrochloride tablets 5 mg, an over-the-counter allergy medication, in the U.S. market. Dr. Reddy’s said its levocetirizine dihydrochloride tablets are a generic version of Xyzal Allergy 24HR Tablets from Chattem-Sanofi. The 5-mg Dr.

Albertsons-Rite Aid merger deal seen as a ‘win-win’

Albertsons-Rite Aid merger deal seen as a ‘win-win’

The merger of Albertsons Cos. and Rite Aid Corp. will create a “truly differentiated” player in the food, health and wellness space, John Standley, chairman and chief executive officer of Rite Aid, said when the deal was announced late last month.

Riedl elects to step down at Walmart

George Riedl, senior vice president at Walmart and president of the Walmart Health and Wellness division, has left the ­company. A Walmart spokeswoman said that Riedl, a key pharmacy executive at the retail giant, departed effective March 16. The company didn’t say if a successor had been named.

Big move by Cigna accelerates health care realignment

Another blockbuster merger is adding momentum to the consolidation wave sweeping through the health care sector, and again crossing industry segments. Health insurer Cigna Corp. plans to acquire pharmacy benefits manager Express Scripts in a $67 billion cash and stock deal.

Time for drug chains to reclaim beauty category

Time for drug chains to reclaim beauty category

It is a pivotal juncture for the beauty care category in the drug channel. Retailers and brands need to devise a game plan to wrest the business away from prestige power players. Sales in cosmetics, skin care and grooming are firing on all cylinders — but sadly, not in the mass beauty